Contraceptive clinical trial network - male sites - contraceptive efficacy clinical trialcontract # HHSN275201300024I/HHSN27500007
Active Awarded Last action
- Contract number
- HHSN27500007
- Awardee
-
Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center UEI LTJVF4QSFCP9
- Awarding agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Obligated
- $12,016,289
Award facts
- Opportunity
-
- NIHNICHDCRHB201204 Solicitation number
- NICHD Contraceptive Clinical Trials Network - Male Sites Award Notice · Posted Apr 2, 2012
- Contract value 100% obligated
- $12,016,289.00 Current and potential, with all options
- Completion date 99% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Torrance, CA 90502, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $224,332 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $301,890 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $2,832,062 | |
| Funding Only Action | $2,321,712 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $3,252,953 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $3,083,340 |
About this award
The National Institute of Child Health and Human Development issued a delivery order to Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center on September 14, 2015, under the NICHD Contraceptive Clinical Trials Network with a ceiling value of $12.016 million for clinical treatment research on Nestorone gel and testosterone gel for male contraception.
Place of performance is Torrance, CA. The order is cost, no fee, with an ultimate completion date of December 31, 2026. The work comprises non-severable clinical trial research on contraceptive efficacy in the male sites network.
SCI-reported labor figures show declining federal-invoiced volume across the order's life. FY2021 through FY2024 averaged 10.8 FTEs across 23,085 contractor hours annually, with derived government-paid hourly rates ranging from $66.31/hr (FY2021) to $96.60/hr (FY2022), settling near $90/hr in FY2023–2024. FY2025 saw sharp contraction to 1.1 FTEs and 2,294 hours at $236.02/hr (a blended rate reflecting increased subcontractor utilization); FY2025 subcontractors performed 15 percent of contractor hours across four vendors. The trend reflects drawdown as the order approaches completion.
Quick answers
Who was awarded contract HHSN27500007?
HHSN27500007 was awarded to Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center by National Institute of Child Health and Human Development (National Institutes of Health) on September 14, 2015.
How much is contract HHSN27500007 worth?
The government has obligated $12,016,289 on HHSN27500007.
Is contract HHSN27500007 an order under another contract?
Yes. HHSN27500007 is a delivery order under HHSN275201300024I, an indefinite delivery contract, on NICHD Contraceptive Clinical Trials Network.
Was contract HHSN27500007 competed?
The extent of competition for HHSN27500007 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award